A Consumer Study on the Sensory Experience of new Herbal Topical Pain Relief Product in India
Main Article Content
Abstract
Introduction: Pain management for musculoskeletal conditions often requires topical products to be used as adjuncts to oral analgesics. The acceptability of topical medication depends on including sensory characteristics, ease of application, after-feel, and residue, etc. This study was conducted to evaluate the consumer acceptability of the sensory parameters of a novel prototype topical pain relief gel containing boswellic acid, methyl salicylate, menthol, and capsaicin in adults who were regular body pain sufferers.
Methods: This was a prospective, quantitative, blinded, monadic-designed, consumer sensory home-use test (HUT), conducted in three cities in India. The study included 320 adults who had musculoskeletal pain or joint pain within the past six months leading up to the study, with the last pain occurring within the preceding four weeks. One group was given the gel formulation of the investigated topical pain relief gel and the other group was given the balm formulation. Participants used the assigned market sample at least three times in a 7-day study period, and then completed a web-based questionnaire on the sensorial aspects of the product.
Results: Over 90% of consumers agreed that the gel formulation provided fast cooling at the usual site of pain in 10 seconds, long-lasting cooling, and dual cooling and warming sensation. Furthermore, it was convenient and easy to use, was absorbed quickly, dried quickly, and had a pleasant smell without greasy after-feel, and left no residue. Significant findings were noted for the gel formulation versus the balm formulation for parameters of cooling.
Conclusion: The findings of the consumer sensory study demonstrate that a novel herbal gel formulation for pain relief has ideal properties of a topical pain relief formulation, and could be a useful adjunct to the pharmacological management of musculoskeletal pain, without adding to the burden of adverse effects.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Kopustinskiene DM, Bernatonyte U, Maslii Y, Herbina N, Bernatoniene J. Natural herbal non-opioid topical pain relievers—Comparison with traditional therapy. Pharmaceutics. 2022;14(12):2648. Available from:
https://www.mdpi.com/1999-4923/14/12/2648.
II. Beaudart C, Biver E, Bruyere O, Cooper C, Al-Daghri N, Reginster JY, et al. Assessment of quality of life in musculoskeletal health. Aging Clin Exp Res. 2018;30(5):413–418. Available from:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5653197/.
III. Garnaes KK, Morkved S, Salvasen O, Tonne T, Furan L, Gronhaug G, et al. What factors are associated with health‐related quality of life among patients with chronic musculoskeletal pain? A cross‐sectional study in primary health care. BMC Musculoskelet Disord. 2021;22(1):102. Available from:
https://bmcmusculoskeletdisord.biomedcentral.com/articles/10.1186/s12891-020-03914-x.
IV. El-Tallawy SN, Nalamasu R, Salem GI, LeQuang JAK, Pergolizzi JV, Christo PJ. Management of musculoskeletal pain: An update with emphasis on chronic musculoskeletal pain. Pain Ther. 2021;10(1):181-209. Available from:
https://link.springer.com/article/10.1007/s40122-021-00235-2.
V. Garg V, Agarwal R, Mendoza K, Lalchandani R, Alcasid Z, Raju G, et al. Counterirritants and sensory profiling of pain-relieving patches. Int J Pharm Biomed Sci. 2022;2(11):466–478. Available from:
https://ijpbms.com/index.php/ijpbms/article/view/166.
VI. Moody ML. Topical medications in the treatment of pain. Available from:
http://www.nationalsalesforce.org/wp-content/uploads/2014/08/Topical-Medications-in-the-Treatment-of-Pain.pdf. Accessed on July 18, 2023.
VII. Kakati R, Ahmed S. Socio-economic classification and its scope in crafting rural segments. ASEAN Marketing J. 2015;7(2):119–138. Available from: http://journal.ui.ac.id/index.php/amj/article/view/5474.
VIII. Green BG, Flammer LJ. Methyl salicylate as a cutaneous stimulus: A psychophysical analysis. Somatosensory Motor Res. 1989;6(3):253–274. Available from:
https://www.tandfonline.com/doi/abs/10.3109/08990228909144676.
IX. Hunter AM, Grigson C, Wade A. Influence of topically applied menthol cooling gel on soft tissue thermodynamics and arterial and cutaneous blood flow at rest. Int J Sports Physical Ther. 2018;13(3):483–492. Available from:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044592/.
X. Pergolizzi JV, Taylor R, LeQuang JA, Raffa RB, NEMA Research Group. The role and mechanism of action of menthol in topical analgesic products. J Clin Pharm Ther. 2018;43(3):313–319.
Available from:
https://onlinelibrary.wiley.com/doi/full/10.1111/jcpt.12679.
XI. Lasanen R, Julkunen P, Airaksinen O, Toyras J. Menthol concentration in topical cold gel does not have significant effect on skin cooling. Skin Res Technol. 2016;22(1):40–45. Available from:
https://onlinelibrary.wiley.com/doi/10.1111/srt.12226.
XII. Johar P, Grover V, Topp R, Behm DG. A comparison of topical menthol to ice on pain, evoked tetanic and voluntary force during delayed onset muscle soreness. Int J Sports Phys Ther. 2012;7(3):314–322. Available from:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3362986/.
XIII. Higashi Y, Kiuchi T, Furuta K. Efficacy and safety profile of a topical methyl salicylate and menthol patch in adult patients with mild to moderate muscle strain: A randomized, double-blind, parallel-group, placebo-controlled, multicenter study. Clin Ther. 2010;32(1):34–43. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0149-2918(10)00017-2.
XIV. Wang J, Zhao X, Chen J, Li X, Hao D, Li T, et al. Efficacy and mechanism of methyl salicylate in the enhancement of skin delivery of herbal medicines. Journal of Traditional Chinese Medical Sciences. 2021;8(4):336–342. Available from:
https://www.sciencedirect.com/science/article/pii/S209575482100065X.
XV. Arora V, Campbell JN, Chung MK. Fight fire with fire: Neurobiology of capsaicin-induced analgesia for chronic pain. Pharmacol Ther.
;220:107743. Available from:
https://www.sciencedirect.com/science/article/pii/S0163725820302746.
XVI. Chung MK, Campbell JN. Use of capsaicin to treat pain: Mechanistic and therapeutic considerations. Pharmaceuticals (Basel). 2016;9(4):66. Available from: https://www.mdpi.com/1424-8247/9/4/66.
XVII. Roy NK, Parama D, Banik K, Bordoloi D, Devi AK, Thakur KK, et al. An update on pharmacological potential of boswellic acids against chronic diseases. Int J Mol Sci. 2019;20(17):4101. Available from:
https://www.mdpi.com/1422-0067/20/17/4101.
XVIII. Barnes TM, Mijaljica D, Townley JP, Spada F, Harrison IP. Vehicles for drug delivery and cosmetic moisturizers: Review and comparison. Pharmaceutics. 2021;13(12):2012. Available from: https://www.mdpi.com/19994923/13/12/2012.